Literature DB >> 27598487

[Survival of older patients starting hemodialysis in Chile].

Álvaro Ríos1, Patricia Herrera2, Álvaro Morales3, Enrique Reynolds2, María Belén Fernández3, Fernando González3.   

Abstract

UNLABELLED: The proportion of older people with end stage renal disease is increasing. Their prognosis is characterized by a high mortality and poor quality of life. AIM: To analyze the survival of patients starting chronic hemodialysis (CHD) according to their age.
MATERIAL AND METHODS: Patients admitted to CHD in the East Metropolitan Health Service of Santiago in a 2-year period were analyzed. Four age groups were created, separating patients older than 70 years in a special group.
RESULTS: During the study period, 459 patients were admitted to CHD and were followed for an average of 27 months. The frequency of cardiovascular comorbidity, cancer, and chronic renal disease of unknown cause (attributed to nephrosclerosis) increased along with age. Mortality was higher at older ages. There was a significant association between starting CHD with a catheter, Charlson comorbidity index and increasing age with mortality. For those aged over 80 years, mortality at three months and one year was 25 and 43% respectively.
CONCLUSIONS: Age, Charlson index and vascular access are predictors of mortality in older adults entering hemodialysis. This study suggests the importance of considering comorbidities, assessment by specialists and creating an arteriovenous fistula in this age group.

Entities:  

Mesh:

Year:  2016        PMID: 27598487     DOI: 10.4067/S0034-98872016000600002

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  1 in total

1.  In-hospital mortality among incident hemodialysis older patients in Peru.

Authors:  Percy Herrera-Añazco; Pedro J Ortiz; Jesus E Peinado; Tania Tello; Fabiola Valero; Adrian V Hernandez; J Jaime Miranda
Journal:  Int Health       Date:  2020-02-12       Impact factor: 2.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.